A study has found that scores of severely ill Covid-19 sufferers survived because they were given the highest form of intensive care in which an artificial lung breathes for them.
According to the research, patients in the UK who underwent extracorporeal membrane oxygenation were more likely to survive than those who did not.
If a person's breathing capacity has collapsed, they are more likely to stay alive if they have an extra vital sign machine.
An analysis of 1,363 people who were treated for severe Covid using a ventilator in the UK between March 2020 and February 2021. They included 243 who were taken by ambulance to either Guy's and St Thomas or the Royal Brompton and Harefield hospital trust in London to try to save their lives.
The other 1,120 were considered to be "perceived futility" because they were considered too old and sick to survive Covid. The doctors had to consider who would benefit the most from the limited availability of artificial life support at the two specialist centres.
Every weekday morning at 7am, you can sign up for First Edition.
The 243 were compared with 206 patients who did not receive ECMO to compare their outcomes.
The study found that 34% of the non-ECMO group died, while the mortality was much lower for those who had the treatment.
Blood is taken from the unconscious patient, put into an oxygenator, and then put back into the patient. The hope is that the extra oxygen will help patients breathe easier.
ECMO saved lives in the UK. The lives of patients were saved due to the efforts of the staff of the National Health Service.
He said that the findings suggest that the survival benefit of SRF delivery is greater than that of conventional therapy.
Several hundred lives were saved during the Pandemic.
The study is a testament to the incredible hard work of the staff in the hospitals who have treated more than one million Covid-19 patients in the last two years.
The study shows that the survival from Covid is higher than in other studies. The results are not directly comparable because of differences between them, such as the selection criteria for deciding which patients received ECMO and whether they were treated in a general hospital or a specialist centre.
The first wave of Covid claimed the lives of 22.9% of the ECMO patients and 52.9% of the non-ECMO patients. During the winter of 2020-21, the mortality went up to 62.4%.
All Rights Reserved © 2024
